Utidelone combined with Bevacizumab

DRUG2 trials

Sponsors

Henan Cancer Hospital, Beijing Biostar Pharmaceuticals Co., Ltd.

Conditions

HER-2 Negative Breast CancerNon-small Cell Lung Cancer Patients with Brain Metastases

Phase 2

Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer

Henan Cancer HospitalHER-2 Negative Breast Cancer

Start: 2022-06-01End: 2024-12-30Target: 71Updated: 2022-06-01

Utidelone Injection Combined with Bevacizumab Injection for Non-small Cell Lung Cancer Patients with Brain Metastases

Not yet recruitingNCT06683703

Beijing Biostar Pharmaceuticals Co., Ltd.Non-small Cell Lung Cancer Patients with Brain Metastases

Start: 2024-12-01End: 2027-12-01Target: 118Updated: 2024-11-12